MedTrace Logo

Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement

NCT04443972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2020-06-23

No results posted yet for this study

Summary

This study will be conducted to evaluate clinically and radiographically the use of PD VitalOs cement® bone graft in the treatment of class II furcation defects comparing with Hydroxyapatite bone graft and biodegradable collagen membrane in the treatment of class II furcation defects.

Conditions

  • Furcation Defects

Interventions

OTHER

PD VitalOs cement®

PD VitalOs cement®\* is a synthetic bone grafting cement designed for bone void filling and bone regeneration in dental surgery

OTHER

Hydroxyapatite bone graft

a bioceramic bone substitute, providing a scaffold for bone deposition

OTHER

biodegardable collagen membrane

provide efficacious barriers that were interposed between the flap and root surface.

Sponsors & Collaborators

  • Alexandria University

    collaborator OTHER

  • Hams Hamed Abdelrahman

    lead OTHER

Principal Investigators

  • Ahmed Hosny Elsayed, BDS · Alexandria University

  • shahira Ali El Damaty, PHD · Alexandria University

  • Gehan Sherif Kotry, PHD · Alexandria University

  • Rania Abd El Aziz Fahmy, PHD · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-12
Primary Completion
2019-07-10
Completion
2020-02-04

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04443972 on ClinicalTrials.gov